Skip to main content
SpringerLink
Log in

Dobutamin bei schwerer Herzinsuffizienz

Mehr Fragen als Antworten

Dobutamine in severe heart failure

More questions than answers

  • Journal Club
  • Published:
Medizinische Klinik - Intensivmedizin und Notfallmedizin Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Abraham WT, Adams KF, Fonarow GC et al (2005) In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 46:57–64

    Article  PubMed  Google Scholar 

  2. Böhm M (2002) Pathophysiologie der Herzinsuffizienz heute. Herz 27:75–91

    Article  PubMed  Google Scholar 

  3. Communal C, Singh K, Sawyer DB et al (1999) Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 100:2210–2212

    Article  PubMed  CAS  Google Scholar 

  4. Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Eur Heart J 29:2388–2442

    Article  PubMed  CAS  Google Scholar 

  5. Follath F, Cleland JG, Just H et al (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360:196–202

    Article  PubMed  CAS  Google Scholar 

  6. Janssens U (2009) Die akute Herzinsuffizienz: Diagnostik und Monitoring. Dtsch Med Wochenschr 134:1287–1292

    Article  PubMed  CAS  Google Scholar 

  7. Janssens U, Graf J (2011) Therapie der akuten Herzinsuffizienz: Good guys and bad guys? Intensiv News 4/11

  8. Kociol RD, Hammill BG, Fonarow GC et al (2010) Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries. Am Heart J 160:885–892

    Article  PubMed  Google Scholar 

  9. Mebazaa A, Nieminen MS, Packer M et al (2007) Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 297:1883–1891

    Article  PubMed  CAS  Google Scholar 

  10. Mebazaa A, Parissis J, Porcher R et al (2011) Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods. Intensive Care Med 37:290–301

    Article  PubMed  Google Scholar 

  11. Tacon CL, McCaffrey J, Delaney A (2011) Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials. Intensive Care Med. doi:10.1007/s00134-011-2435-6

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehung hin: Vortragshonorar von der Firma Abbott.

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin, St.-Antonius-Hospital, Dechant-Deckers-Str. 8, 52249, Eschweiler, Deutschland

    U. Janssens

Authors
  1. U. Janssens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to U. Janssens.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janssens, U. Dobutamin bei schwerer Herzinsuffizienz. Med Klin Intensivmed Notfmed 107, 63–66 (2012). https://doi.org/10.1007/s00063-012-0077-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00063-012-0077-2

Search

Navigation